-
1
-
-
38049165722
-
-
American College of Rheumatology [online] [Accessed 2009 Jul 29]
-
American College of Rheumatology. Fibromyalgia (fact sheet) [online]. Available from URL: http://www.rheumatology. org/public/factsheets/diseases-and- conditions/fibromyalgia. pdf [Accessed 2009 Jul 29]
-
Fibromyalgia (Fact Sheet)
-
-
-
2
-
-
68849104318
-
Fibromyalgia: A complex syndrome requiring a multidisciplinary approach
-
Spaeth M, Briley M. Fibromyalgia: a complex syndrome requiring a multidisciplinary approach. Hum Psycho-pharmacol Clin Exp 2009; 24 Suppl.: S3-10
-
(2009)
Hum Psycho-pharmacol Clin Exp
, vol.24
, Issue.SUPPL.
-
-
Spaeth, M.1
Briley, M.2
-
3
-
-
0025266660
-
-
The American College of Rheumatology 1990 criteria for the classification of fibromyalgia
-
Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 1990; 33 (2): 160-172
-
(1990)
Arthritis Rheum
, vol.33
, Issue.2
, pp. 160-172
-
-
Wolfe, F.1
Smythe, H.A.2
Yunus, M.B.3
-
4
-
-
31044442025
-
Fibromyalgia diagnosis: A comparison of clinical, survey, and American College of Rheumatology criteria
-
Katz RS, Wolfe F, Michaud K. Fibromyalgia diagnosis: a comparison of clinical, survey, and American College of Rheumatology criteria. Arthritis Rheum 2006; 54 (1): 169-176
-
(2006)
Arthritis Rheum
, vol.54
, Issue.1
, pp. 169-176
-
-
Katz, R.S.1
Wolfe, F.2
Michaud, K.3
-
5
-
-
60249084829
-
Treatment options and patient perspectives in the management of fibromyalgia: Future trends
-
Lawson K. Treatment options and patient perspectives in the management of fibromyalgia: future trends. Neuro-psych Dis Treat 2008; 4 (6): 1059-1071
-
(2008)
Neuro-psych Dis Treat
, vol.4
, Issue.6
, pp. 1059-1071
-
-
Lawson, K.1
-
6
-
-
68849093756
-
Fibromyalgia: Pathways and neurotransmitters
-
Stahl SM. Fibromyalgia: pathways and neurotransmitters. Hum Psychopharmacol Clin Exp 2009; 24 Suppl.: S11-7
-
(2009)
Hum Psychopharmacol Clin Exp
, vol.24
, Issue.SUPPL.
-
-
Stahl, S.M.1
-
8
-
-
53549087538
-
Pregabalin: A review of its use in fibromyalgia
-
Lyseng-Williamson KA, Siddiqui MA. Pregabalin: a review of its use in fibromyalgia. Drugs 2008; 68 (15): 2205-2223
-
(2008)
Drugs
, vol.68
, Issue.15
, pp. 2205-2223
-
-
Lyseng-Williamson, K.A.1
Siddiqui, M.A.2
-
9
-
-
67649356935
-
Duloxetine: In patients with fibromyalgia
-
Curran MP. Duloxetine: in patients with fibromyalgia. Drugs 2009; 69 (9): 1217-1227
-
(2009)
Drugs
, vol.69
, Issue.9
, pp. 1217-1227
-
-
Curran, M.P.1
-
10
-
-
73349083453
-
-
Forest Pharmaceuticals Inc [online] [Accessed 2009 Jun 22]
-
Forest Pharmaceuticals Inc. Savella® (milnacipran HCl) tablets: US prescribing information [online]. Available from URL: http://www.frx.com/pi/ Savella-pi.pdf[Accessed 2009 Jun 22]
-
Savella® (Milnacipran HCl) Tablets: US Prescribing Information
-
-
-
11
-
-
0031661167
-
Milnacipran: A review of its use in depression
-
Sep
-
Spencer CM, Wilde MI. Milnacipran: a review of its use in depression. Drugs 1998 Sep; 56 (3): 405-427
-
(1998)
Drugs
, vol.56
, Issue.3
, pp. 405-427
-
-
Spencer, C.M.1
Wilde, M.I.2
-
12
-
-
0022401405
-
Biochemical profile of midalcipran (F2207), 1-phenyl-1-diethyl- aminocarbonyl-2-aminomethyl-cyclopropane (Z) hydrochloride, a potential fourth generation antidepressant drug
-
Moret C, Charveron M, Finberg JP, et al. Biochemical profile of midalcipran (F2207), 1-phenyl-1-diethyl-aminocarbonyl-2-aminomethyl-cyclopropane (Z) hydrochloride, a potential fourth generation antidepressant drug. Neuropharmacology 1985; 24 (12): 1211-1219
-
(1985)
Neuropharmacology
, vol.24
, Issue.12
, pp. 1211-1219
-
-
Moret, C.1
Charveron, M.2
Finberg, J.P.3
Al, E.4
-
13
-
-
0033972686
-
Pharmaco-dynamics of milnacipran in young and elderly volunteers
-
Feb
-
Hindmarch I, Rigney U, Stanley N, et al. Pharmaco-dynamics of milnacipran in young and elderly volunteers. Br J Clin Pharmacol 2000 Feb; 49: 118-125
-
(2000)
Br J Clin Pharmacol
, vol.49
, pp. 118-125
-
-
Hindmarch, I.1
Rigney, U.2
Stanley, N.3
-
14
-
-
0742324808
-
Double-blind comparative study of the action of repeated administration of milnacipran versus placebo on cognitive functions in healthy volunteers
-
Poirier MF, Galinowski A, Amado I, et al. Double-blind comparative study of the action of repeated administration of milnacipran versus placebo on cognitive functions in healthy volunteers. Hum Psychopharmacol Clin Exp 2004; 19: 1-7
-
(2004)
Hum Psychopharmacol Clin Exp
, vol.19
, pp. 1-7
-
-
Poirier, M.F.1
Galinowski, A.2
Amado, I.3
-
15
-
-
0027745755
-
Acute electrophysiological effects of intravenous milnacipran, a new antidepressant agent
-
Dec
-
Caron J, Libersa C, Hazard JR, et al. Acute electrophysiological effects of intravenous milnacipran, a new antidepressant agent. Eur Neuropsychopharmacol 1993 Dec; 3: 493-500
-
(1993)
Eur Neuropsychopharmacol
, vol.3
, pp. 493-500
-
-
Caron, J.1
Libersa, C.2
Hazard, J.R.3
-
16
-
-
73349124243
-
Precuneus contrast distinguishes milnacipran from placebo: An fMRI study in fibromyalgia patients
-
[abstract no. 857.19/HH2]. Presented at the Nov 15-19; Washington, DC
-
Ingvar M, Petzke F, Marcus H, et al. Precuneus contrast distinguishes milnacipran from placebo: an fMRI study in fibromyalgia patients [abstract no. 857.19/HH2]. Presented at the 38th Annual Meeting for the Society for Neuro-science; 2008 Nov 15-19; Washington, DC
-
(2008)
38th Annual Meeting for the Society for Neuro-science
-
-
Ingvar, M.1
Petzke, F.2
Marcus, H.3
-
17
-
-
73349096343
-
Milnacipran: Beyond a role of antidepressant
-
Pae C-U, Marks DM, Shah M, et al. Milnacipran: beyond a role of antidepressant. Clin Neuropharmacol 2009; 32 (6): 355-363
-
(2009)
Clin Neuropharmacol
, vol.32
, Issue.6
, pp. 355-363
-
-
Pae, C.-U.1
Marks, D.M.2
Shah, M.3
-
18
-
-
68849113241
-
Functional magnetic resonance imagery (fMRI) in fibromyalgia and the response to milnacipran
-
Mainguy Y. Functional magnetic resonance imagery (fMRI) in fibromyalgia and the response to milnacipran. Hum Psychopharmacol Clin Exp 2009; 24 Suppl.: S19-23
-
(2009)
Hum Psychopharmacol Clin Exp
, vol.24
, Issue.SUPPL.
-
-
Mainguy, Y.1
-
19
-
-
6344285317
-
Serotonin and noradrenaline reuptake inhibitors in animal models of pain
-
Mochizucki D. Serotonin and noradrenaline reuptake inhibitors in animal models of pain. Hum Psychopharmacol Clin Exp 2004; 19 Suppl.: S15-9
-
(2004)
Hum Psychopharmacol Clin Exp
, vol.19
, Issue.SUPPL.
-
-
Mochizucki, D.1
-
20
-
-
73349111687
-
Milnacipran's effect on body weight by baseline BMI: Results across 3 randomized, double-blind, placebo-controlled fibromyalgia trials
-
Presented at the Oct 17-21; Philadelphia (PA)
-
Arnold LM, Palmer RH, Hufford MR, et al. Milnacipran's effect on body weight by baseline BMI: results across 3 randomized, double-blind, placebo-controlled fibromyalgia trials. Presented at the 73rd Annual American College of Rheumatology Meeting; 2009 Oct 17-21; Philadelphia (PA)
-
(2009)
73rd Annual American College of Rheumatology Meeting
-
-
Arnold, L.M.1
Palmer, R.H.2
Hufford, M.R.3
-
21
-
-
64849117499
-
The efficacy and safety of milnacipran for treatment of fibromyalgia: A randomized, double-blind, placebo-controlled trial
-
Feb
-
Mease PJ, Clauw DJ, Gendreau RM, et al. The efficacy and safety of milnacipran for treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial. J Rheumatol 2009 Feb; 36 (2): 398-409
-
(2009)
J Rheumatol
, vol.36
, Issue.2
, pp. 398-409
-
-
Mease, P.J.1
Clauw, D.J.2
Gendreau, R.M.3
-
22
-
-
57649234533
-
Milnacipran for the treatment of fibromyalgia in adults: A 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial
-
Nov
-
Clauw DJ, Mease P, Palmer RH, et al. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther 2008 Nov; 30 (11): 1988-2004
-
(2008)
Clin Ther
, vol.30
, Issue.11
, pp. 1988-2004
-
-
Clauw, D.J.1
Mease, P.2
Palmer, R.H.3
-
23
-
-
73349106575
-
Milnacipran 100mg/day in the treatment of fibromyalgia: A randomized, double-blind, placebo-controlled trial
-
Poster presented at the Oct 16-21; Philadelphia (PA)
-
Arnold LM, Gendreau RM, Spera A, et al. Milnacipran 100mg/day in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial. Poster presented at the 73rd Annual Scientific American College of Rheumatology Meeting; 2009 Oct 16-21; Philadelphia (PA)
-
(2009)
73rd Annual Scientific American College of Rheumatology Meeting
-
-
Arnold, L.M.1
Gendreau, R.M.2
Spera, A.3
-
24
-
-
70349300638
-
In vitro inhibition and induction of human liver cytochrome P450 enzymes by milnacipran
-
Paris BL, Ogilvie BW, Scheinkienig JA, et al. In vitro inhibition and induction of human liver cytochrome P450 enzymes by milnacipran. Drug Metab Disp 2009; 37 (10): 2045-2054
-
(2009)
Drug Metab Disp
, vol.37
, Issue.10
, pp. 2045-2054
-
-
Paris, B.L.1
Ogilvie, B.W.2
Scheinkienig, J.A.3
Al, E.4
-
25
-
-
0009560424
-
Absolute bioavailability study of midalcipran (F 2207) in volunteers
-
Apr 21-24; Freiburg, Switzerland
-
Puozzo C, Rostin M, Montastruc JL, et al. Absolute bioavailability study of midalcipran (F 2207) in volunteers. In: Third European Congress of Biopharmaceutics and Pharmacokinetics Proceedings; 1987 Apr 21-24; Freiburg, Switzerland, 59-68
-
(1987)
Third European Congress of Biopharmaceutics and Pharmacokinetics Proceedings
, pp. 59-68
-
-
Puozzo, C.1
Rostin, M.2
Montastruc, J.L.3
Al, E.4
-
26
-
-
0000019544
-
Plasma levels of F 2207, midalcipran, a novel antidepressant, after single oral administration in volunteers
-
Puozzo C, Filaquier C, Briley M. Plasma levels of F 2207, midalcipran, a novel antidepressant, after single oral administration in volunteers. Br J Clin Pharmacol 1985; 20: 291P
-
(1985)
Br J Clin Pharmacol
, vol.20
-
-
Puozzo, C.1
Filaquier, C.2
Briley, M.3
-
27
-
-
0029827287
-
Pharmacokinetics of milnacipran in comparison with other antidepressants
-
Sep
-
Puozzo C, Leonard BE. Pharmacokinetics of milnacipran in comparison with other antidepressants. Int Clin Psycho-pharmacol 1996 Sep; 11 (Suppl. 4): 15-27
-
(1996)
Int Clin Psycho-pharmacol
, vol.11
, Issue.SUPPL. 4
, pp. 15-27
-
-
Puozzo, C.1
Leonard, B.E.2
-
28
-
-
24344447705
-
Lack of interaction of milnacipran with the cytochrome P450 isoenzymes frequently involved in the metabolism of antidepressants
-
Puozzo C, Lens S, Reh C, et al. Lack of interaction of milnacipran with the cytochrome P450 isoenzymes frequently involved in the metabolism of antidepressants. Clin Phar-macokinet 2005; 44 (9): 977-988
-
(2005)
Clin Phar-macokinet
, vol.44
, Issue.9
, pp. 977-988
-
-
Puozzo, C.1
Lens, S.2
Reh, C.3
-
29
-
-
70349727760
-
Milnacipran for the treatment of fibromyalgia syndrome: A European multicenter, double-blind, placebo-controlled trial
-
[abstract no. P.8.a.014] Aug
-
Branco J, Bragee G, Zachrisson O, et al. Milnacipran for the treatment of fibromyalgia syndrome: a European multicenter, double-blind, placebo-controlled trial [abstract no. P.8.a.014]. Eur Neuropsychopharmacol 2008 Aug; 18 Suppl. 4: S574-5
-
(2008)
Eur Neuropsychopharmacol
, vol.18
, Issue.SUPPL. 4
-
-
Branco, J.1
Bragee, G.2
Zachrisson, O.3
-
31
-
-
6344231258
-
A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia
-
Oct
-
Vitton O, Gendreau M, Gendreau J, et al. A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia. Hum Psychopharmacol 2004 Oct; 19 Suppl. 1: S27-35
-
(2004)
Hum Psychopharmacol
, vol.19
, Issue.SUPPL. 1
-
-
Vitton, O.1
Gendreau, M.2
Gendreau, J.3
-
32
-
-
26444518188
-
Efficacy of milnacipran in patients with fibromyalgia
-
Oct
-
Gendreau RM, Thorn MD, Gendreau JF, et al. Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol 2005 Oct; 32 (10): 1975-1985
-
(2005)
J Rheumatol
, vol.32
, Issue.10
, pp. 1975-1985
-
-
Gendreau, R.M.1
Thorn, M.D.2
Gendreau, J.F.3
-
33
-
-
1542514939
-
An open-label clinical trial of milnacipran in fibromyalgia syndrome with co-morbid depressive symptoms
-
Nagaoka S, Ohno M, Sekiguchi A. An open-label clinical trial of milnacipran in fibromyalgia syndrome with co-morbid depressive symptoms. Int JPsych Clin Pract 2004; 8 (1): 47-51
-
(2004)
Int JPsych Clin Pract
, vol.8
, Issue.1
, pp. 47-51
-
-
Nagaoka, S.1
Ohno, M.2
Sekiguchi, A.3
-
34
-
-
33644807054
-
The fibromyalgia impact questionnaire (FIQ): A review of its development, current version, operating characteristics and uses
-
Bennett R. The fibromyalgia impact questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol 2005; 23 Suppl. 39: S154-62
-
(2005)
Clin Exp Rheumatol
, vol.23
, Issue.SUPPL. 39
-
-
Bennett, R.1
-
35
-
-
70349349593
-
Improvements in fibro-myalgia symptoms are sustained for 1 year with milnacipran treatment: Results from a dose-controlled, extension study
-
[abstract no. 583]
-
Mease P, Palmer RH, Rao S, et al. Improvements in fibro-myalgia symptoms are sustained for 1 year with milnacipran treatment: results from a dose-controlled, extension study [abstract no. 583]. Arthritis Rheum 2008; 58 (9 Suppl.): S383
-
(2008)
Arthritis Rheum
, vol.58
, Issue.9 SUPPL.
-
-
Mease, P.1
Palmer, R.H.2
Rao, S.3
|